Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sirolimus for Complicated Vascular Anomalies
NCT04172922Phase 1Terminated
- Sponsor
- Nemours Children's Health
- Start
- Apr 2020
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sirolimus in vascular anomaly, sponsored by Nemours Children's Health. Primary endpoints: Reduction in Pain or local irritation at 24 weeks, Cyst formation at 24 weeks and 1 more. Started Apr 2020; status: terminated.
02
Drugs
sirolimus
03
Conditions
vascular anomaly
Beyond the preview
Go deeper on NCT04172922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04172922.